e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities
Wojciech Trzepizur, Jérôme Boursier, Marc Le Vaillant, Pierre-Henri Ducluzeau, Séverine Dubois, Samir Henni, Pierre Abraham, Christophe Aubé, Paul Calès, Frédéric Gagnadoux
Source:
Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
Journal Issue:
June
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wojciech Trzepizur, Jérôme Boursier, Marc Le Vaillant, Pierre-Henri Ducluzeau, Séverine Dubois, Samir Henni, Pierre Abraham, Christophe Aubé, Paul Calès, Frédéric Gagnadoux. Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities. Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017
Neck circumference predicts the cardiovascular and metabolic abnormalities associated with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 214s
Year: 2002
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Increased arterial stiffness in patients with obstructive sleep apnea: clinical implication
Source: Sleep and Breathing Conference 2021
Year: 2021
High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
A comparison of respiratory functions, peripheral muscle strength and postural impairments between patients with different severity of obstructive sleep apnea syndrome (OSAS)
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020
APAP impact on metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Independent association between obstructive sleep apnea severity and liver stiffness
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept